Skip to Main Content

Paper Details

Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a meta-regression of 5-year outcomes in phase III randomized controlled trials.
Prostate Cancer Prostatic Dis
8
2022
DM, androgen, localized prostate cancer, patient, patients, prostate cancer
Author NameAffiliation
Daniela MarkovicUniversity of California los angeles
Jay PatelDavid Geffen School of Medicine, University of California los angeles
Jesus E JuarezDavid Geffen School of Medicine, University of California los angeles
Ting Martin MaDavid Geffen School of Medicine, University of California los angeles
David ShabsovichDavid Geffen School of Medicine, University of California los angeles
Nicholas G NickolsDavid Geffen School of Medicine, University of California los angeles
Robert E ReiterDavid Geffen School of Medicine, University of California los angeles
David ElashoffUniversity of California los angeles
David ElashoffUniversity of California los angeles
Matthew B RettigDavid Geffen School of Medicine, University of California los angeles
Matthew B RettigVA Greater Los Angeles Healthcare System
Nicholas G ZaorskyPenn State Cancer Institute
Daniel E SprattUniversity of Michigan ann arbor
Amar U KishanDavid Geffen School of Medicine, University of California los angeles
Amar U KishanDavid Geffen School of Medicine, University of California los angeles
  • 1 - 15

Datasets

Release 1.2